French startup Naox Technologies this month became the first company to receive FDA 510(k) clearance for an in-ear EEG device. The system seeks to improve care for neurological conditions like epilepsy, Alzheimer’s and sleep disorders by capturing brain activity in everyday settings that traditional scalp-based EEGs often miss.
By moving beyond subjective and heterogeneous criteria and embracing objective brain function measures, the field of psychiatry can achieve greater precision and efficacy in addressing complex disorders.
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
Medical device company Zeto received clearance for its EEG brain monitoring system. The system includes a user-friendly, comfortable EEG headset designed to be easily operated by any medical professional with minimal training.
Beacon Biosignals technology analyzes EEGs to find insights brain activity. The company will use its new Series A financing to build alliances with more biopharmaceutical companies looking for insights about how their experimental brain therapies are working.
Alphabet’s “moonshot” subsidiary X shared that it failed to find a single biomarker for depression and anxiety. But the company still plans to make its research, which included developing portable EEGs, available to the public.
The Israeli startup is helping jolt patients out of depression - commercializing a device stateside that harnesses MRI technology to stimulate deep brain tissue to improve mental illness.
Alan Murray on improving access for medical transportation.
Neuroelectrics, a Spanish startup developing a cap filled with sensors and electrodes that works like an EEG, is in the midst of a $20 million fundraise for its promising device. But scientists are already asking: Is this just hype?